Bayer | BAYN - Cost Of Sales



Bayer reported EUR4.36B in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Air Liquide EUR 6.32B 1.28B Jun/2025
Akzo Nobel EUR 1.59B 23M Jun/2025
Alcon AG USD 1.21B 118M Jun/2025
Amarin USD 16.89M 18.51M Mar/2025
Arkema EUR 1.94B 0 Jun/2025
AstraZeneca USD 2.47B 232M Jun/2025
BASF EUR 11.59B 957M Jun/2025
Bayer EUR 4.36B 1.26B Jun/2025
Beiersdorf EUR 2.11B 130M Jun/2025
Corteva USD 3.09B 751M Jun/2025
Covestro EUR 2.83B 185M Jun/2025
Essilor EUR 5.31B 2.79B Jun/2025
Fresenius EUR 4.12B 117M Jun/2025
Fresenius Medical Care EUR 3.58B 120M Jun/2025
Genmab DKK 57M 15M Jun/2025
Givaudan CHF 1.05B 936.5M Jun/2024
GlaxoSmithKline GBP 2.16B 241M Jun/2025
GRIFOLS EUR 1.15B 56.19M Jun/2025
Henkel EUR 5.07B 260M Jun/2025
Hikma Pharmaceutical USD 895M 82M Dec/2024
Johnson Matthey GBP 5.55B 329M Mar/2025
Linde USD 4.31B 14M Jun/2025
Lonza CHF 2.47B 532M Dec/2024
Merck EUR 2.23B 93M Jun/2025
Novartis USD 3.32B 95M Jun/2025
Nutrien USD 7.26B 3.48B Jun/2025
Philips EUR 2.33B 79M Jun/2025
PPG Industries USD 2.57B 425M Jun/2025
Roche Holding CHF 4.13B 393.5M Dec/2024
Sanofi EUR 2.99B 103M Jun/2025
SAP EUR 2.38B 23M Jun/2025
Solvay EUR 960M 31M Jun/2025
UCB EUR 901M 50M Dec/2024
Umicore EUR 8.22B 4.83B Jun/2025
Vinci EUR 9.07B 632M Jun/2025